Ocugen, Inc.
OCGN
$1.39
-$0.07-4.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.41M | 5.37M | 4.75M | 4.52M | 4.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.41M | 5.37M | 4.75M | 4.52M | 4.06M |
| Cost of Revenue | 39.75M | 37.37M | 34.33M | 34.83M | 32.13M |
| Gross Profit | -35.34M | -32.00M | -29.58M | -30.31M | -28.07M |
| SG&A Expenses | 27.58M | 27.76M | 25.81M | 26.74M | 26.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 178.00K | 1.31M | -14.00K | -14.00K | -14.00K |
| Total Operating Expenses | 67.51M | 66.44M | 60.13M | 61.55M | 58.80M |
| Operating Income | -63.09M | -61.07M | -55.37M | -57.03M | -54.74M |
| Income Before Tax | -67.85M | -64.02M | -56.94M | -57.48M | -54.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -67.85 | -64.02 | -56.94 | -57.48 | -54.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.85M | -64.02M | -56.94M | -57.48M | -54.05M |
| EBIT | -63.09M | -61.07M | -55.37M | -57.03M | -54.74M |
| EBITDA | -59.71M | -57.68M | -52.33M | -54.33M | -52.78M |
| EPS Basic | -0.23 | -0.22 | -0.20 | -0.21 | -0.20 |
| Normalized Basic EPS | -0.14 | -0.14 | -0.12 | -0.13 | -0.13 |
| EPS Diluted | -0.23 | -0.22 | -0.20 | -0.21 | -0.20 |
| Normalized Diluted EPS | -0.14 | -0.14 | -0.12 | -0.13 | -0.13 |
| Average Basic Shares Outstanding | 1.20B | 1.18B | 1.15B | 1.12B | 1.08B |
| Average Diluted Shares Outstanding | 1.20B | 1.18B | 1.15B | 1.12B | 1.08B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |